Gilead Has Outperformed the S&P 500. But is its Valuation Still Attractive?

Gilead Sciences, Inc. (NASDAQ:GILD) has had a considerably better year than the broader market. The stock has surged by over 24% since the start of the year, compared with a 14% return for the S&P 500. The rally has changed the valuation equation. Yahoo Finance recently put Gilead’s normalized forward P/E at approximately 15.5 times. […]